Sana Biotechnology Appoints Brian Piper as CFO; Aptevo CEO Marvin White to Step Down in April; Violett Names Scott Kushino CEO
Brian Piper was appointed CFO and executive vice president at Sana Biotechnology, while Marvin White will step down as Aptevo CEO in April, succeeded by COO Jeff Lamothe. Additionally, Scott Kushino became CEO of Seattle startup Violett, and several other leadership changes occurred across Seattle and New York tech companies.
Paresh Rajwat Steps Down as Meta Pacific Northwest Leader; Phase Genomics Hires David Shoultz as Chief Business Officer
Paresh Rajwat stepped down this summer as Meta's Pacific Northwest head after 10 years, shifting to angel investing and advising startups. Seattle biotech Phase Genomics appointed David Shoultz as its first chief business officer to boost adoption of its DNA sequencing technologies.
Sana Biotechnology Opens $80M Manufacturing Facility in Bothell to Scale Cancer and Gene Therapy Production
Sana Biotechnology inaugurated its new 80,000 square-foot manufacturing facility in Bothell, Washington, dedicated to producing its proprietary cancer drug program and future therapies. The company, known for its gene-editing technology and multiple drugs in human trials including for cancer, autoimmune diseases, and type 1 diabetes, sees this expansion as a key step in advancing scalable cell and gene therapies.
See all 18 news stories about Steve Harr.
Seattle Flow is free for everyone.
- Claim and edit your profile
- Get alerts about you, your company, and anything else you care about
- Access the most comprehensive investor list in Seattle
- Join the conversation on news, podcasts, and events
Organizations
-
Sana Biotechnology Co-founder and President and Chief Executive Officer · current